DEL ROSS, TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.078
AS - Asia 191
EU - Europa 135
AF - Africa 1
Totale 1.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.073
SG - Singapore 90
CN - Cina 76
IT - Italia 56
JP - Giappone 21
FI - Finlandia 15
DE - Germania 14
FR - Francia 14
GB - Regno Unito 10
SE - Svezia 10
MX - Messico 5
CZ - Repubblica Ceca 4
HK - Hong Kong 3
NL - Olanda 3
BE - Belgio 2
IE - Irlanda 2
RU - Federazione Russa 2
UA - Ucraina 2
GR - Grecia 1
IN - India 1
MA - Marocco 1
Totale 1.405
Salva come PNG Salva come JPEG
Città #
Fairfield 220
Chandler 129
Woodbridge 84
Houston 81
Ashburn 76
Singapore 74
Seattle 51
Cambridge 49
Ann Arbor 44
Wilmington 43
Santa Clara 39
Padova 30
Boardman 25
San Diego 20
Medford 17
Princeton 17
Dearborn 13
Roxbury 13
Beijing 12
Des Moines 11
Helsinki 10
Mito 10
Nanjing 10
Tsukuba 9
New York 8
Milan 6
London 5
Allauch 4
Brno 4
Falkenstein 3
Hebei 3
Hong Kong 3
Jiaxing 3
Amsterdam 2
Atlanta 2
Brixen 2
Brussels 2
Bussero 2
Castelfranco Emilia 2
Dallas 2
Dublin 2
Hanover 2
Harbin 2
Herndon 2
Jinan 2
Kilburn 2
Kunming 2
Los Angeles 2
Ogden 2
Shenyang 2
Venice 2
Washington 2
Arzignano 1
Casablanca 1
Castello di Godego 1
Changsha 1
Chengdu 1
Chiswick 1
Citta 1
Dongguan 1
Esslingen am Neckar 1
Frankfurt am Main 1
Hangzhou 1
Kharkiv 1
Nanchang 1
Piraeus 1
Prescot 1
St Petersburg 1
Tianjin 1
Wandsworth 1
Xian 1
Zhengzhou 1
Totale 1.184
Salva come PNG Salva come JPEG
Nome #
Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report 115
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 106
Clinical and laboratory characteristics of isolated lupus anticoagulants 106
Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus 106
The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome 97
Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study 89
Erosive hand osteoarthritis and systemic sclerosis: A casual association? 86
Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study 84
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 82
Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients 76
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study 73
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study 64
Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays 63
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. 61
IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers. 59
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies. 51
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome: a nationwide survey 33
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study 32
High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets 23
Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome 19
Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome 1
Totale 1.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.830
article - articoli 6.830
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020153 0 0 0 0 0 20 26 28 32 17 8 22
2020/2021166 11 30 4 18 2 17 2 24 18 4 24 12
2021/2022266 23 26 26 7 6 26 12 20 10 12 21 77
2022/2023223 44 37 2 34 24 28 6 12 23 5 6 2
2023/2024171 7 40 20 11 5 30 13 7 7 1 10 20
2024/2025214 4 71 26 33 54 26 0 0 0 0 0 0
Totale 1.426